Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Classification of Illness01:17

Classification of Illness

7.9K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple Myeloma Screening Education: A Community-Based Health Literacy Intervention.

Cancer research communications·2026
Same author

Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early Therapy.

Cancers·2026
Same author

AI in Oncology: Opportunity and Accountability.

Journal of the advanced practitioner in oncology·2026
Same author

The first case of Teclistamab interference with serum electrophoresis and immunofixation.

Clinical chemistry and laboratory medicine·2026
Same author

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance.

Journal of the advanced practitioner in oncology·2026
Same author

Many Titles, One Mission: Advancing Team-Based Care in Oncology.

Journal of the advanced practitioner in oncology·2026

Related Experiment Video

Updated: Sep 2, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K

A Focus on Relapsed Multiple Myeloma.

Kimberly Noonan1, Sandra Rome2, Beth Faiman3

  • 1Dana-Farber Cancer Institute, Boston, Massachusetts.

Journal of the Advanced Practitioner in Oncology
|August 8, 2022
PubMed
Summary

Multiple myeloma (MM) is a relapsing cancer. Advanced practitioners guide patients through treatment options, monitoring, and shared decision-making for improved quality of life and adherence.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.1K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K

Related Experiment Videos

Last Updated: Sep 2, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.1K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Background:

  • Multiple myeloma (MM) is a hematologic malignancy characterized by relapse in many patients.
  • Treatment options for relapsed MM are available, necessitating careful management by healthcare providers.

Purpose of the Study:

  • To outline the role of advanced practitioners in managing relapsed multiple myeloma.
  • To emphasize personalized treatment approaches and shared decision-making in relapsed MM care.

Main Methods:

  • Review of diagnostic criteria for relapsed myeloma, including biomarkers, imaging, and clinical assessment.
  • Discussion of personalized treatment strategies considering patient preferences and clinical trial participation.
  • Highlighting the importance of patient education and empowerment in managing the disease.

Main Results:

  • Relapsed MM management requires a personalized approach based on disease characteristics and patient desires.
  • Prognosis is influenced by baseline and evolving disease characteristics, including cytogenetic abnormalities.
  • Shared decision-making improves patient quality of life and treatment adherence.

Conclusions:

  • Advanced practitioners play a crucial role in managing relapsed multiple myeloma by setting expectations and monitoring disease.
  • Personalized treatment and patient empowerment through shared decision-making are key to optimizing outcomes in relapsed MM.
  • Understanding disease progression and treatment options enhances patient quality of life and adherence.